Earnings Per Share

Shares (Diluted)

Revolution Medicines, Inc. Shares (Diluted) increased by 4.7% to 198.1M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.3%, from 188.1M to 198.1M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionEarnings Per Share
CategoryCapital Allocation
SignalLower is better
VolatilityStable
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026

How to read this metric

An increase indicates potential dilution from employee compensation or convertible instruments, which can reduce earnings per share.

Detailed definition

The weighted-average number of common shares outstanding plus the effect of all potentially dilutive securities, such as...

Peer comparison

Standard metric for all public companies; essential for understanding the impact of equity-based compensation.

Metric ID: weighted_shares_diluted

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value73.4M73.5M74.2M74.3M84.7M94.8M106.9M109.2M164.7M165.1M166.8M188.1M188.6M189.2M198.1M
QoQ Change+0.2%+0.9%+0.2%+14.0%+12.0%+12.7%+2.2%+50.8%+0.3%+1.0%+12.8%+0.2%+0.3%+4.7%
YoY Change+1.2%+15.2%+27.9%+43.9%+29.0%+73.7%+54.5%+52.7%+14.2%+14.2%+13.4%+5.3%
Range73.4M198.1M
CAGR+32.8%
Avg YoY Growth+28.8%
Median YoY Growth+21.5%
Current Streak14+ quarters growth

Frequently Asked Questions

What is Revolution Medicines, Inc.'s shares (diluted)?
Revolution Medicines, Inc. (RVMD) reported shares (diluted) of 198.1M in Q1 2026.
How has Revolution Medicines, Inc.'s shares (diluted) changed year-over-year?
Revolution Medicines, Inc.'s shares (diluted) increased by 5.3% year-over-year, from 188.1M to 198.1M.
What does shares (diluted) mean?
The average number of shares outstanding including all potential shares that could be created.